Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05387447 · ClinicalTrials.gov registry record · NA

The Loneliness Epidemic Tailoring Interventions to Reduce Loneliness and Pain

A NA study of Pain, Chronic and Loneliness, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
58
Enrollment target
4
Study locations

NCT05387447 is a NA study of Pain, Chronic and Loneliness that has completed, run by University of Nebraska. The registered enrollment target is 58 participants, below the 720-participant average among 48 other Pain, Chronic trials with a reported enrollment target (92% lower). The trial reports 4 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05387447, a NA study of Pain, Chronic and Loneliness, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
58 participants
Enrollment target
4
Study locations

Study Summary

Approximately 24% of community-dwelling older adults are socially isolated, and over 40% of adults 60 and older report feeling lonely. Over 50% of midlife and older adults who perceive their health as fair or poor are lonely in contrast to 27% percent who believe their health to be excellent or very good. Loneliness has been associated with high mortality and inflammation which can influence symptoms such as pain. Social isolation and pain further contribute to loneliness. Studies have reported one and a half greater odds of being socially isolated among older adults with clinical osteoarthritis (OA) of the hip and/or knee than someone with similar characteristics without OA. Pain is significant because it is highly prevalent among older adults and is associated with disability, social isolation, and greater costs and burden to health care systems. A recent review of the literature found that several interventions influence social isolation and loneliness. As these interventions require in-person interaction, those who are socially isolated or distanced due to pain may not benefit due to a lack of access. Current advancements in technology and social media may provide opportunities to reduce loneliness and pain due to social isolation. Online and technology-based interventions have shown potential to engage older adults to improve communication and social connection. Given that socialization with these approaches are supportive only when the other person is available for that interaction. An intervention that utilizes technology to incorporate solitary interventions may be efficacious. Studies found a trend for a positive relationship between the use of a voice assistant and loneliness in aging adults living alone. Building upon this evidence on loneliness and pain research, conversational voice assistant (CVA) technology and personalized persuasion, investigators will conduct a 12-week randomized control pilot with older adults that live alone and self-report pain

Conditions Studied

Interventions

  • BEHAVIORAL Conversational Voice Assistant (Enhanced)
  • BEHAVIORAL Conversational Voice Assistant (Standard)

Study Locations (4)

Nebraska

  • The Legacy - Lincoln
  • Eastmont Senior Living Apartments - Lincoln
  • Trinity Courtyard - Omaha
  • Aksarben Village Senior Apartments - Omaha

Trial Details

FieldValue
Enrollment Target 58 participants
Start Date 2022-03-01
Est. Completion 2023-12-30
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT05387447

The ClinicalTrials.gov registry entry for NCT05387447 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 720-participant average among 48 other Pain, Chronic trials with a reported enrollment target (92% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Pain, Chronic appearing as the primary indexed condition, and to 2 interventions - of which Conversational Voice Assistant (Enhanced) is the first listed.

NCT05387447 reports 4 study locations spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT05387447 about?

NCT05387447 is a clinical study titled "The Loneliness Epidemic Tailoring Interventions to Reduce Loneliness and Pain". Approximately 24% of community-dwelling older adults are socially isolated, and over 40% of adults 60 and older report feeling lonely. Over 50% of midlife and older adults who perceive their health as fair or poor are lonely in contrast to 27% percent who believe their health to be excellent or very...

What is the current status of trial NCT05387447?

This trial is currently completed. It is a NA study. The enrollment target is 58 participants. The study started on 2022-03-01. Estimated completion is 2023-12-30.

What conditions does trial NCT05387447 study?

This clinical trial studies the following conditions: Pain, Chronic, Loneliness.

What interventions are being tested in trial NCT05387447?

The interventions under investigation include: Conversational Voice Assistant (Enhanced) (BEHAVIORAL), Conversational Voice Assistant (Standard) (BEHAVIORAL).

Who is sponsoring clinical trial NCT05387447?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05387447 being conducted?

This trial has 4 study locations across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain, Chronic

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.